Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages
about
Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's diseaseDo the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Abeta peptide-induced inflammatory mediators in astroglia.Statins in heart failure: do we need another trial?Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's diseaseSystemic simvastatin rescues retinal ganglion cells from optic nerve injury possibly through suppression of astroglial NF-κB activationStatin therapy and autoimmune disease: from protein prenylation to immunomodulationInduction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophagesTransfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cellsActivation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells.New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeuticsMAPK p38 regulates transcriptional activity of NF-kappaB in primary human astrocytes via acetylation of p65.Adrenoleukodystrophy and related disorders.The effects of atorvastatin in experimental autoimmune uveitisChemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments.Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of StrokeThiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Statins in candidemia: clinical outcomes from a matched cohort study.Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trialSmall G proteins in islet beta-cell function.Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses.Simvastatin protects bladder and renal functions following spinal cord injury in rats.Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.Statin use and Parkinson's disease in Denmark.Burkholderia pseudomallei transcriptional adaptation in macrophages.Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.Protection of Tregs, suppression of Th1 and Th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.HMG-CoA Reductase Inhibition Promotes Neurological Recovery, Peri-Lesional Tissue Remodeling, and Contralesional Pyramidal Tract Plasticity after Focal Cerebral Ischemia.Role of nitric oxide and CCAAT/enhancer-binding protein transcription factor in statin-dependent induction of heme oxygenase-1 in mouse macrophages.Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammationCinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.Hypolipemic agents for stroke prevention.Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Neuroprotective effect of atorvastatin in spinal cord ischemia-reperfusion injury.Specific PKC isoforms regulate LPS-stimulated iNOS induction in murine microglial cellsPyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation.Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke.Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disordersProspects of statins in Parkinson disease
P2860
Q24629942-5BCA4FAA-EB95-4288-B120-D6E0C13F09A1Q24804153-873ED0AB-A4C3-4A98-A3C4-ED38E56FD13CQ24815455-DB7696D7-1496-46A7-85A1-887348C1AB8FQ26998966-6133DF51-86C4-4CC4-8394-5773FB7BDFDCQ27301885-E00986BB-C3F3-415E-9C19-86F20B365536Q27335272-62F68D72-8B1A-4BDF-8C4A-C641535B8AA4Q28236647-9F819E2C-31E6-438C-8BA6-E83DE5F8BA67Q28506067-6596B57A-9C96-4B08-81B3-D41BC18E4437Q28583643-59843790-BCC2-4FD8-9224-02F908AA34DEQ29568315-FA25598F-BF58-4E7B-A41E-BFF27559D9F0Q30371980-CC1B6E10-9CCF-4F35-8571-91C6643FF862Q30439375-712950D6-1109-426B-8606-0065FB3E49D1Q30660504-5F0F29E7-9C82-49CB-BA27-CEE21EB83C4FQ33212135-684F538A-DE2A-419C-A706-6CD3DB6E41AEQ33214417-A744AAEA-88BF-4395-81C3-B29A594FA3A8Q33565967-D20E752B-082A-456F-A223-EDA90AE2253BQ33585657-DF29C3EA-28C4-44BE-94C1-B07201FDD2A0Q33595333-A88770C8-0BCF-4248-90E8-F4B46B23BB01Q33610240-423C9E8A-A34D-4421-A030-E89C0C6786C9Q33646487-6C2B988D-FA5B-4D2A-83FC-FE5857417514Q33779672-C93D7F13-4862-472C-BBCA-544002706A61Q33822381-DF1A9C89-26BF-4141-87EF-8BA339BC1911Q33864425-751A5DD4-7EB2-4413-9BDB-43D2CC7F0442Q33941922-D62A5485-6CCE-4776-BB2D-C79B6436F5AEQ34020626-C664D3F9-0907-4340-809B-FD68270AA636Q34347994-F948254B-1E38-432D-BBEA-FB0974D26B0DQ34448370-39175EB8-91DF-477E-852E-E8F7B1C75A7CQ34532426-25907FF3-FF85-412F-856B-CD36EAE69F16Q34677525-B934D93A-5643-41A5-82DE-AE0415D14654Q34745152-87B5E062-8B47-4162-8C98-C2DFBB41AA46Q34762159-B8863573-6001-4DC7-A330-9BD29E087135Q34876505-F41A17F0-32ED-4349-9A2E-12A9E7C83807Q35008533-95752F61-4096-42A6-83F1-A7AD1E03964DQ35016920-DC9ED193-E87E-4E64-B8C0-5A1399F6CF5EQ35029109-7FD20FB4-8D62-421F-8765-CE2BB02E2147Q35031301-46D7D239-4AA3-4421-925E-45775FA3F4A2Q35044007-4F8258FF-0178-4BF8-98DB-E01818D3CE2BQ35075417-D5066A19-6594-4345-8680-846548C486A4Q35087574-49827CAE-A113-4A57-A5B0-2CC34C1C2E4AQ35094028-6C9EAA3F-70AE-4DFD-8A5A-0D9A5525BFBE
P2860
Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@ast
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@en
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@nl
type
label
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@ast
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@en
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@nl
prefLabel
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@ast
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@en
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@nl
P2093
P2860
P921
P356
P1476
Lovastatin and phenylacetate i ...... es, microglia, and macrophages
@en
P2093
P2860
P304
P356
10.1172/JCI119812
P407
P577
1997-12-01T00:00:00Z